Britain’s Covid vaccine rollout will go at twice its speed so far over the next three months potentially doubling the number of people immunised by June as well as dishing out second doses, the UK’s vaccine minister says.
Nadhim Zahawi said today that March will be a ‘very big month’ for the programme. February saw a slowdown in the mammoth operation as vaccine manufacturers struggled to keep pace with the NHS’s demand.
But with supply issues resolved and tens of millions more jabs becoming available in March, including the first batches of a third approved vaccine, made by US company Moderna, the health service is planning to turbocharge the rollout.
Boris Johnson has laid out his ambition to vaccine all over-50s – half of the UK population – at least once by the middle of March, and to offer a jab to every adult in Britain by the end of July.
The UK this weekend hit the milestone of vaccinating 20million people and today expanded the scheme to invite everyone aged 60 or over to come forward.
If the programme can work double-time in March, as Mr Zahawi claims, it could mean those who got their first vaccines in December and early January could get their second while another 20million people get their first.
Mr Zahawi told BBC Breakfast: ‘March will be a very big month for us. We’ll probably going to be twice the rate over the next 10 weeks as we have done over the past 10 or 11 weeks.’
Ministers on Friday decided to continue working through the population by age groups and have made it to people in their early 60s so far, but some younger people are lucking out and scooping up spare doses of the jab that are left behind by appointment no-shows.
Even healthy people in their 20s say they have had vaccines already because a local jab clinic has had doses going spare at the end of the day, meaning more of the population could get covered ahead of schedule.
UK vaccines minister Nadhim Zahawi said today that the NHS rollout could double in speed over the next 11 weeks, allowing it to continue vaccinating new people at the same rate as now while also dishing out growing numbers of second doses
The UK this weekend hit the milestone of vaccinating 20million people and today expanded the scheme to invite everyone aged 60 or over to come forward
Mr Zahawi on Breakfast today reassured people that they would begin getting invites for their second vaccine doses soon, and that there were enough supplies for everyone to get another jab of the same type as the first one.
He said: ‘We have already been for now over 10 days reserving second doses.
‘You have seen the numbers tick up of second doses – yesterday I think we were at 800,000 second doses.
‘And in March you will see that number increase even more, because obviously those who had the first dose in January will be getting their second dose.
‘The NHS have got all the protocols in place to deliver that, as well as of course continuing to do the first dose.
‘March will be a very big month for us. We’ll probably going to be twice the rate over the next 10 weeks as we have done over the past 10 or 11 weeks.’
Nearly two million people aged between 60 and 63 in England will be invited to receive their first coronavirus jab from today, while over-40s will start being called for jabs later this month.
Health officials will send out 1.9million letters to those over 60 inviting them to book a coronavirus jab, meaning that by the end of the week everyone in the top seven priority groups – including clinically vulnerable younger people and those with underlying conditions – will have been contacted.
NHS England said the programme, which has been proceeding at breakneck speed, will then move to offer vaccinations to around 5million people in their 50s as soon as next week, which should take two weeks to deliver.
With about 2.5million people receiving their first dose of the vaccine per week, Britain is on course to offer jabs to everyone over the age of 50 by the week beginning March 15 – almost a month before its target – with the over-40s then expected to receive invitations later this month.
But younger people are already getting their vaccines by lucking out when doses are going spare at their local clinics.
People even in their 20s have managed to scoop up a jab ahead of schedule by being in the right place at the right time.
Twitter user Tracey Spencer said her 27-year-old son, a police officer, managed to get a vaccine in February because the local clinic had jabs ‘left at the end of the day by non takers’.
Cobain Schofield, a 26-year-old in Liverpool, told The Sunday Times he had got a vaccine when a colleague told him some were going spare at the local clinic. He said: ‘There was something of a movie cliché moment where everyone looks at each other before jumping in their cars and going… I didn’t want to be taking it from someone who should be getting it. When I arrived I asked the clerk if they were genuinely spare, and she replied, “Yes, there are lots”.’
And Bridget Burke said in a tweet that her husband received a spare vaccine despite not being on the priority list. She said: ‘I was so grateful they agreed to vaccinate him. The roll out is amazing.’
Scientific findings have revealed that just one shot reduces the risk of hospitalisation by more than 90 per cent.
Public health officials have told ministers that the remarkable results apply for both the Pfizer and Oxford-AstraZeneca vaccine, with the British jab proving slightly more effective.
And in another huge boost to Britain’s world-beating vaccine, 386,948 additional vaccine doses were registered in England on Saturday, with 27,876 in Scotland and 14,634 in Wales, tipping the number of total people vaccinated past the 20 million milestone.
Prime Minister Boris Johnson said on social media that it was a ‘huge national achievement’ and praised the NHS staff, volunteers and armed forces for their work in the vaccine rollout.
He tweeted: ’20 million people across the UK have now got the jab – a huge national achievement and a testament to the tireless work of NHS staff, volunteers, the Armed Forces & many more. I urge everyone to get the jab when called. Every jab makes a difference in our battle against Covid.’
Health Secretary Matt Hancock said vaccinating more than 20million people against coronavirus across the UK is a ‘magnificent achievement for the country’.
In a video on his Twitter, Mr Hancock said: ‘I’m absolutely delighted that over 20million people have now been vaccinated across the UK – it’s absolutely fantastic.
‘I want to thank every single person who’s come forward to get the jab because we know with increasing confidence that the jab protects you, it protects your community and it also is the route out of this for all of us.’
Mr Hancock urged everyone eligible for the vaccine to come forward and added: ‘Every jab in the arm is another life soon to be protected from this awful disease and means we are a step closer to returning to our normal lives.’
Mr Zahawi tweeted: ‘BINGO! One Score over 20,000,000 people have had the vaccination (1s dose). What an achievement for February 2021. What a team! Proud to be with you on this journey.’
NHS England chief executive Sir Simon Stevens said: ‘Vaccinating 20 million people – including 17 million across England – in a few short weeks shows the NHS vaccination campaign is firing on all cylinders, and looking out to Easter and beyond it’s full speed ahead.
Vaccine boost propels Boris Johnson and the Tories to a seven-point poll lead
The numbers suggest Mr Johnson is enjoying a ‘vaccine boost’ as the Government’s roll-out of
Some 36 per cent now approve, an increase of three points, while 45 per cent disapprove which is unchanged. Approval of the Government’s handling of the vaccine roll-out has also gone up.
Some 68 per cent of respondents approve of the job ministers are doing, up six per cent, while 12 per cent disapprove.
Overall, the poll puts the Tories on 43 per cent and Labour on 36 per cent in terms of general election voting intention.
‘As we can see from other parts of the world, having vaccines from the manufacturers versus actually administering them to patients can be two different things.
‘So this latest milestone is also a tribute to careful health service planning, effective organisation and amazing teamwork across the whole of the country.’
It comes as nearly two million people aged 60 to 63 in England are being invited to book a coronavirus jab, with the letters due to start arriving on Monday.
NHS England said the letters will explain how people can make an appointment through the national booking service.
They have been sent out after more than three in four people aged 65 to 70 took up the offer of a vaccination, it added.
A further 149 people who tested positive for coronavirus have died in hospital in England, bringing the total number of confirmed deaths reported in hospitals to 83,123, NHS England said on Sunday.
Patients were aged between 23 and 103 and all except six, aged between 34 and 89, had known underlying health conditions.
The deaths were between January 8 and February 27.
Meanwhile, Chancellor Rishi Sunak told the BBC’s Andrew Marr Show there is no evidence of newly discovered coronavirus variants spreading after concerns that case rates are rising in one in five areas.
He added: ‘That’s not what I’ve seen in any of the data.’
Pressed if there was any evidence of more new variants, he said: ‘No.’
Mr Sunak also said the Government should reach its conclusion on vaccine passports in ‘a few months’ time’ and that the Prime Minister had taken a ‘cautious but irreversible approach’ with his road map but there was a ‘sense of confidence and optimism about the future’.
Asked if the data was better than expected, the PM’s road map could happen quicker, he told Sky News’ Sophy Ridge On Sunday: ‘What we want is a cautious but irreversible approach.
‘That’s why we’ve taken the approach that we have and those will be the earliest dates that we think we can do the various things we’ve laid out.’
He added: ‘What businesses don’t want is a stop-start approach to this, we want to know that it’s a one-way road and that’s why it’s cautious.
‘We’ve given the earliest of dates to give a sense of timing and a sense of direction and then obviously we might have to adjust those if things are not going exactly as we would like, but look the early signs are promising.
EU nations including Germany are being far outpaced by Britain in the vaccine race after Brussels was late to place orders with firms including Pfizer and AstraZeneca
A single shot of either the Oxford-AstraZeneca or Pfizer jab cuts the chance of needing hospital treatment by more than 90 per cent, ‘real world’ results from the NHS vaccination programme show
Hunt for MISSING UK patient with Brazilian Covid strain: Farcical search for traveller with ‘more resistant’ mutant who didn’t fill out form – after six cases are found but scientists say vaccines WILL likely still work
A hunt for the missing Covid patient thought to be one of the first people in Britain to have the Brazilian mutant variant has begun after health officials last night admitted that they have no idea who the infected person is or where they were tested.
Public Health England (PHE) yesterday announced that six cases of the strain, which scientists fear could be more resistant to vaccines, have been detected.
Three cases have been found in North East Scotland after flying into Aberdeen from Brazil via Paris and London, the Scottish Government said – while two cases were confirmed in South Gloucestershire.
However, the sixth case has not been located and could be anywhere in the nation as the person did not complete their test registration card – meaning that their contact details are unavailable.
The Gloucestershire cluster was said to originate from one individual who travelled back from Brazil and arrived in London on February 10 – five days before the Government’s quarantine hotel regime came into force.
There are concerns that vaccines might be less effective against the Brazilian strain, with trials of the Johnson & Johnson jab finding it was slightly less effective in Latin America at preventing mild or moderate cases. However, the trials found it still prevented hospitalisations and deaths.
No studies have tested the Oxford/AstraZeneca vaccine against the P1 variant, while Moderna and Pfizer say their mRNA coronavirus vaccines should work against variants with the E484K mutation, with early results showing that these vaccines are only slightly less effective against the P1 variant.
NHS Medical Director Professor Stephen Powis immediately sought to calm public fears about the variant by explaining that vaccines can be quickly adapted to tackle new strains.
Officials said the missing case is not believed to be linked to the others because the virus was found to have slight genetic differences, and said their test was processed on February 14 – meaning that it is likely they took it a day or possibly two earlier.
They believe that person is unlikely to have taken their test at one of the regional test sites, where staff can check contact details, but it could have been a home test or from local surge testing.
Health officials have now issued an appeal asking anyone who took a test on either February 12 or 13 and who has not received a result or has an incomplete test registration card to come forward immediately.
They are also tracking down hundreds of passengers on Swiss Air flight, LX318 travelling from Sao Paulo, through Zurich, and landing in Heathrow on February 10, and will deploy ‘surge testing’ in five areas of the county to hunt down any more cases.
‘We’re seeing great news with the rollout of the vaccine, not just the take-up of it but also the efficacy of the vaccine, the data that we’re getting is showing us that it is working, so I think that should give us all a sense of confidence and optimism about the future that we can make progress on that road map and hopefully slowly get our lives back to normal.’
Prince William urged Britons to ignore conspiracy theories about the supposed dangers of the vaccine, warning of ‘rumours and misinformation’ on social media. The Duke of Cambridge issued the warning during a video call with his wife Kate to two clinically vulnerable women who have been shielding with their families since March.
A Mail on Sunday investigation into the poor take-up among some ethnic minorities finds people are falling for lies and conspiracy theories spread online.
The new one-dose vaccination figures were calculated by comparing Covid hospitalisation rates in those who have received their first dose with those of a similar age who haven’t.
It helps to explain why the numbers being hospitalised are falling so rapidly in the oldest age groups.
Deaths among the over-75s have dropped by 40 per cent, while the number of over-85s being admitted to intensive care units with Covid has dropped close to zero.
The strong results for the Oxford vaccine are a rebuke to the German authorities, which last month advised against its use in the over-65s.
The Duke of Cambridge’s remarks on vaccinations come after the Queen suggested last week that it was selfish to refuse a jab.
William and Kate spoke to mother of two Shivali Modha, who has type 2 diabetes, and said she was anxious about her vaccine after reading claims on social media.
In a video call, the Duke told her: ‘Catherine and I are not medical experts by any means but if it’s any consolation we can wholeheartedly support having vaccinations. It’s really, really important.
‘We’ve spoken to a lot of people about it and the uptake has been amazing so far.
‘We’ve got to keep it going so the younger generations also feel that it’s really important for them to have it.
‘So it’s great that, Shivali, you’re taking the time to work it out and come to the conclusion that ‘I need to do this’ because social media is awash sometimes with lots of rumours and misinformation, so we have to be a bit careful who we believe and where we get our information from. Especially for those who are clinically vulnerable as well, it’s so important that those vaccinations are done, so good luck.’
The Duke and Duchess also spoke to Fiona Doyle, 37 – an asthma sufferer – and her seven-year-old daughter Ciara, who have been shielding at home in Finchley, North London, since the crisis began.
She spoke of her anxiety ‘knowing that there was this virus out there that was incredibly dangerous for me. It was really difficult.’
The challenges facing the NHS were made clear by one GP who told the MoS of his battle to persuade one of his surgery’s receptionists to have the inoculation.
The doctor, who works at a busy South of England group practice which is co-ordinating vaccinations for the local area, explained: ‘She said that she didn’t want to have it.
‘So one evening I sat down with her and talked through her concerns for 20 minutes. I explained all about how rigorously the vaccine had been tested, how safe it is and how important it was that as many people as possible have it.
‘Not to mention the fact that she was working at a surgery where we are seeing lots of elderly and vulnerable people every day.
‘But there was just no convincing her. She told me that the vaccine was something ‘foreign’ and she didn’t want it going in her body. And that was the end of that.’
A survey by the Harrow Association of Somali Voluntary Organisations suggested only half of its community plan to take the vaccine – even though more than three-quarters knew someone who had died from the disease and barely any doubted its dangers.
In an ignominious climbdown, health chiefs in both countries have now suggested they could update their policies for the Oxford University researched jab after initially refusing to give it to the over 65s.
France changes its tune on AstraZeneca jabs following Ursula von der Leyen’s praise for the vaccine
France’s government has said it wants to ‘rehabilitate’ the AstraZeneca vaccine as EU leaders try to undo the doubts they sowed about the jab which have led to low uptake despite its proven effectiveness.
The French health ministry admitted that the Oxford/AstraZeneca vaccine had an ‘image deficit’ which had led to ‘feeble’ usage of the jab, with only 107,000 people immunised with it so far.
It comes after Emmanuel Macron himself raised doubts about the jab’s effectiveness and claimed that Britain had taken a risk by authorising it so soon, while French regulators refused to approve it for over-65s.
Meanwhile the French government is considering new local restrictions to deal with a worsening Covid-19 situation as it scrambles to avoid a new national lockdown.
‘We will use all possible levers to rehabilitate the vaccine,’ the French health ministry said, according to Le Telegramme, days after real-world data in Scotland showed the AstraZeneca shot reducing Covid hospitalisations by 94 per cent.
Germany’s government is also pleading with people to take the AstraZeneca jab, while EU chief Ursula von der Leyen said that she herself would take it – despite her furious row with the drugmaker last month over missing shipments to the EU.
That struggle is set to continue into the spring with as many as 90million doses missing from AstraZeneca shipments in the second quarter of 2021.
An EU official involved in talks with the firm says AstraZeneca has warned that it may deliver only half of its promised 180million doses from April to June, having slowed supplies in January because of delays at a Belgian factory.
The new shortage could hamper the EU’s ability to meet its target of vaccinating 70 per cent of adults by summer – with Britain promising to offer one dose to 100 per cent by July 31.
The EU supply shortage is seen as one of the main reasons for a widely-criticised vaccine roll-out which is lagging far behind that in Britain.
While the UK has handed out 27.0 doses per 100 people, the EU is lagging behind on 6.2 and has not significantly sped up its progress in recent weeks.
Von der Leyen defended her policies by pointing out that the EU had handed out 27milion doses in total compared to 17million in Britain – but the bloc of 27 countries has a population more than six times larger.
She also noted that Italy had given double-doses to more people than Britain, but it has handed out far fewer doses overall.
Catching up to Britain will be made even harder if AstraZeneca shortfalls continue into the early summer, as an EU official told Reuters last night.
Von der Leyen told the Augsburger Allgemeine that ‘I would take the AstraZeneca vaccine without a second thought, just like Moderna’s and BioNTech/Pfizer’s products,’
Organisers said they were shocked by the results.
It is even better than the
A single shot of either jab cuts the chance of needing hospital treatment by more than 90 per cent, ‘real world’ results from the
But the Oxford-AstraZeneca vaccine, shunned by millions across Europe because of concerns over trial data, is proving slightly more effective at stopping severe Covid-19 illness than the Pfizer jab.
Its apparent superiority even holds among over-70s, The Mail on Sunday understands, vindicating the UK drug regulator’s decision to approve it for use in older people.
The results are a massive boost not just for Oxford and AstraZeneca, but also the Government. Ministers have ordered 100 million doses, making it the workhorse of the NHS vaccination campaign.
The landmark results will add to growing confidence that vaccination is breaking the link between infections and deaths.
The figures were calculated by comparing Covid hospitalisation rates across England in those who have received a first dose of vaccine in the NHS rollout, to those of a similar age who have not.
They follow a Scottish study of Covid hospitalisation rates, published last week, which came to similar conclusions.
Edinburgh University researchers found that by the fourth week after injection, ‘the Pfizer and Oxford-AstraZeneca vaccines were shown to reduce the risk of hospitalisation from Covid-19 by up to 85 per cent and 94 per cent, respectively’.
Among over-80s, who are at highest risk of severe illness, a single dose cut the risk of needing hospital treatment by 81 per cent from week four onwards, when the results from both types were combined.
Well-placed sources said the larger English study found hospitalisation rates in over-70s were slightly lower among recipients of the Oxford vaccine than those who got the Pfizer drug. Last month, German authorities advised against using the Oxford vaccine in over-65s, citing lack of evidence of effectiveness from formal trials. The trials were dogged by low numbers of older volunteers.
French President Emmanuel Macron then caused consternation by falsely claiming the Oxford vaccine was ‘quasi-ineffective’ for over-65s – although he has since rowed back by saying he would have it.
In a subtle riposte to European critics, Professor Sarah Gilbert, who spearheaded Oxford’s Covid vaccine project, said real-world data ‘now provides evidence of high effectiveness of both the Oxford-AstraZeneca and BioNTech-Pfizer vaccines in preventing hospitalisation in people over the age of 80, after a single dose, supporting our confidence in using this vaccine in adults of all ages.’
The results are already having a stunning impact on Covid statistics, which show hospitalisations and deaths falling fastest among Britain’s oldest people.
Deaths in over-75s – almost all of whom have now had their first jab – fell 40 per cent in the last week. By contrast, they fell 23 per cent in under-65s, who remain largely unvaccinated.
The number of Covid admissions to intensive care units among over-85s has also dropped to near zero in the last couple of weeks, Public Health England reports indicate.
In another boost for Oxford, new evidence also indicates one dose of its vaccine provides more durable protection. Updated trial results show that from three weeks to three months after first dose, the vaccine was 76 per cent effective at preventing symptomatic infection and ‘protection did not wane’.
Protection from one Pfizer dose dipped from 84 per cent five weeks after injection, to 58 per cent after more than six weeks.
Last night it emerged that Germany is reconsidering its recommendation on the Oxford vaccine.
Professor Thomas Mertens, head of the country’s vaccination commission, said there will be ‘a new, updated recommendation very soon’, the newspaper Der Spiegel reported.
He also lamented the fallout from their January decision, saying they ‘never criticised the vaccine’, only the lack of data in over-65s. He added: ‘However, the whole thing went somehow bad.’
But the Oxford-AstraZeneca vaccine, shunned by millions across Europe because of concerns over trial data, is proving slightly more effective at stopping severe Covid-19 illness than the Pfizer jab
Germany and France look set to approve the AstraZeneca Covid jab for the over 65s in a major U-turn aimed at speeding up their shambolic vaccine drives. Pictured: A near empty vaccination centre in Germany earlier this month
The NHS vaccine programme is already having an impact on the number of people being hospitalised due to Covid-19
As well as reducing the number of hospitalisations, the number of deaths is also falling since the widespread rollout of the vaccine among the elderly
Tips to Find Low Priced Luxury Holiday Package Deals Fast